Table 1.
Study/Year | Study type | Modified Downs/Black score | Quality problems |
---|---|---|---|
Schmidt 2017 |
|
8/13 | Unclear whether investigators and statisticians were blinded to the intervention group during analyses. Unclear whether randomization allocation was concealed from providers. Lack of comprehensive set of adjustment variables such as severity of illness, etc. |
Chien et al. 201718 | RCTb | 10/13 | Unclear whether investigators and statisticians were blinded to the intervention group during analyses. Unclear whether randomization allocation was concealed from the providers. |
Sedrak et al. 201721 | RCTb | 12/13 | Lack of randomization at the level of clinician in the study design. However, this was not pursued to prevent contamination between groups |
Conway et al. 201719 | Retrospective; Interrupted time-series | 8/13 | Retrospective and non-randomized design, Lack of comprehensive set of adjustment variables such as severity of illness, etc. |
Chien 201720 | RCTb | 10/13 | Unclear whether investigators and statisticians were blinded to the intervention group during analyses. Unclear whether randomization allocation was concealed from the providers |
Fang et al. 201417 | Prospective comparative | 6/13 | Non-randomized design. Interrupted time series design not employed. Analyses done between two groups recruited over differing periods of time. Control cohort differs from intervention cohort in baseline characteristics. |
Durand et al. 201316 | RCTb | 8/13 | Unclear whether investigators and statisticians were blinded to the intervention group during analyses. Lack of comprehensive set of adjustment variables such as severity of illness etc. Lack of randomization at the level of clinician in the study design. However, this was not pursued to prevent contamination between groups |
Feldman et al. 201315 | RCTb | 10/13 | Unclear whether investigators and statisticians were blinded to the intervention group during analyses. Lack of comprehensive set of adjustment variables such as severity of illness, etc. Lack of randomization at the level of clinician in the study design. However, this was not pursued to prevent contamination between groups |
Horn 201414 | Interrupted time series with a control group | 6/13 | Non- randomized design. Significant baseline differences in characteristics of patients seen by the intervention and control group of providers. This was not controlled for. Chronic disease burden in the two groups was not mentioned |
Ornstein et al. 199913 | Controlled clinical trial | 7/13 | Non- randomized design. No concurrent control (historical control was used). Lack of estimation of chronic illness burden in the intervention and control periods. |
Bates et al. 199712 | RCTb | 11/13 | Unclear whether investigators and statisticians were blinded to the intervention group during analyses |
Vedsted et al. 199711 | Controlled trial | 8/13 | Non-randomized design. Unclear whether investigators and statisticians were blinded to the intervention group during analyses. Lack of comprehensive multifactorial analyses |
Tierney et al. 199010 | RCTb | 10/13 | Lack of comprehensive multifactorial analyses. Intervention period coincided with the period of arrival of new trainees and this was not controlled for in the analyses |
Blinding study subjects (providers) to the intervention was not possible in any study due to the nature of intervention.
Randomized controlled trial.